tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Nierengarten, 393 are a BUY (82.56%), 77 are a HOLD (16.18%), 6 are a SELL (1.26%).
Analyst David Nierengarten, currently employed at WEDBUSH, carries an average stock price target met ratio of 43.95% that have a potential upside of 42.99% achieved within 231 days.
David Nierengarten’s has documented 977 price targets and ratings displayed on 80 stocks. The coverage is on Healthcare, Communication Services, Technology, Energy sectors.
Most recent stock forecast was given on NUVB, Nuvation Bio at 02-Apr-2026.
Analyst best performing recommendations are on SRRK (SCHOLAR ROCK HOLDING CORP).
The best stock recommendation documented was for SRRK (SCHOLAR ROCK HOLDING CORP) at 6/18/2018. The price target of $25 was fulfilled within 1 day with a profit of $3.57 (16.66%) receiving and performance score of 166.59.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Feb-2024
$95
$37.32 (64.70%)
$72
9 days ago
(31-Mar-2026)
0/5 (0%)
$39.54 (71.29%)
Buy Since 30-Sep-2025
$66
$8.32 (14.42%)
$66
10 days ago
(30-Mar-2026)
15/16 (93.75%)
$10.61 (19.16%)
229
Buy Since 17-Mar-2026
$90
$32.32 (56.03%)
$70
23 days ago
(17-Mar-2026)
0/2 (0%)
$22.71 (33.75%)
Buy Since 28-Feb-2025
$85
$27.32 (47.36%)
$56
1 months 4 days ago
(05-Mar-2026)
2/3 (66.67%)
$27.72 (48.39%)
213
Buy Since 20-Jan-2026
$79
$21.32 (36.96%)
$78
1 months 5 days ago
(04-Mar-2026)
0/2 (0%)
$18.45 (30.47%)
Which stock is David Nierengarten is most bullish on?
Which stock is David Nierengarten is most reserved on?
What Year was the first public recommendation made by David Nierengarten?
